XML 107 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Disclosures (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31:


Years ended December 31
20242023
Operating expenses:
     Clinical product candidates$65,285 $68,999 
     Pre-clinical product candidates979 1,995 
     Employee costs- research and development7,854 6,917 
     Employee costs-general and administrative5,315 4,478 
     Non-cash stock compensation8,527 7,102 
     Depreciation expense 134 111 
     Professional fees and other segment expenses9,958 9,621 
Total operating expenses98,052 99,223 
Loss from operations(98,052)(99,223)
     Interest Income3,390 3,075 
     Change in fair value of the tranche rights(4,796)— 
     Other income (expense)(1,049)2,536 
Net loss$(100,507)$(93,612)